Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2013-05-29 | Dr. Jacobs broad management expertise in the pharmaceutical and biotechnology industries provides relevant experience in a number of strategic and operational areas and led to the Boards conclusion that he should serve as a director of our company. |
| 2014-07-23 | Dr. Jacobs broad management expertise in the pharmaceutical and biotechnology industries provides relevant experience in a number of strategic and operational areas and led to the Boards conclusion that he should serve as a director of our company. |
| 2015-10-16 | Gary S. Jacob As of December 31, 2014, 123,672 stock options were outstanding, of which 105,388 were exercisable. |
Data sourced from SEC filings. Last updated: 2026-02-03